This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Use of ECMO in Acute MI

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2007 by Johann Wolfgang Goethe University Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Johann Wolfgang Goethe University Hospital
ClinicalTrials.gov Identifier:
NCT00425685
First received: January 22, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
  Purpose
ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.

Condition
ECMO and Acute MI

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective
Official Title: Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures

Further study details as provided by Johann Wolfgang Goethe University Hospital:

Estimated Enrollment: 60
Study Start Date: January 2003
Estimated Study Completion Date: December 2006
Detailed Description:
Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.
  Eligibility

Ages Eligible for Study:   17 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Acute MI

Exclusion Criteria:

  • Contraindication against ECMO
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00425685

Sponsors and Collaborators
Johann Wolfgang Goethe University Hospital
Investigators
Principal Investigator: Farhad Bakhtiary, MD JW Goethe University
  More Information

ClinicalTrials.gov Identifier: NCT00425685     History of Changes
Other Study ID Numbers: Use of ECM in acute MI
ECMO and AMI
Study First Received: January 22, 2007
Last Updated: January 22, 2007

Keywords provided by Johann Wolfgang Goethe University Hospital:
cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.

ClinicalTrials.gov processed this record on June 22, 2017